|
Volumn 88, Issue 5, 2012, Pages 352-354
|
What is the appropriate treatment for the management of rectal Chlamydia trachomatis in men and women?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AZITHROMYCIN;
DOXYCYCLINE;
ARTICLE;
CHLAMYDIASIS;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG EFFICACY;
DRUG TREATMENT FAILURE;
FEMALE;
HUMAN;
INFECTION RISK;
MAJOR CLINICAL STUDY;
MALE;
PRIORITY JOURNAL;
PROSPECTIVE STUDY;
RECTAL CHLAMYDIA TRACHOMATIS INFECTION;
REINFECTION;
SINGLE DRUG DOSE;
TREATMENT OUTCOME;
ANTI-BACTERIAL AGENTS;
AZITHROMYCIN;
CHLAMYDIA INFECTIONS;
CHLAMYDIA TRACHOMATIS;
DOXYCYCLINE;
FEMALE;
GREAT BRITAIN;
HUMANS;
MALE;
PROSPECTIVE STUDIES;
RECTAL DISEASES;
TREATMENT OUTCOME;
|
EID: 84864274329
PISSN: 13684973
EISSN: 14723263
Source Type: Journal
DOI: 10.1136/sextrans-2011-050466 Document Type: Article |
Times cited : (55)
|
References (4)
|